DNASE1L3 as an indicator of favorable survival in hepatocellular carcinoma patients following resection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

DNASE1L3 as an indicator of favorable survival in hepatocellular carcinoma patients following resection

Published:2020-01-24 Issue:2 Volume:12 Page:1171-1185
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Wang Shuncong¹²³,Ma Haiqing¹³,Li Xuemin¹³,Mo Xiangqiong⁴,Zhang Haiyu¹,Yang Lewei¹,Deng Yun¹,Yan Yan¹,Yang Guangwei¹³,Liu Xingwei³⁴,Sun Huanhuan³⁵

Affiliation:

1. Department of Oncology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, Guangdong, China

2. KU Leuven, Campus Gasthuisberg, Faculty of Medicine, Leuven 3000, Belgium

3. Guangdong Provincial Key Laboratory of Biomedical Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai 519000, Guangdong, China

4. Department of General Surgery, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, Guangdong, China

5. Central Laboratory, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, Guangdong, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Ageing

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Constructing a prognostic model for hepatocellular carcinoma based on bioinformatics analysis of inflammation-related genes;Frontiers in Medicine;2024-07-11

2. Deoxyribonuclease 1‐like 3 inhibits colorectal malignancy through antagonizing NEDD4‐triggered CDKN1A ubiquitination;Cell Biology International;2023-12-18

3. Integrative analysis of deoxyribonuclease 1-like 3 as a potential biomarker in renal cell carcinoma;Translational Andrology and Urology;2023-08

4. A novel prognostic signature based on immunogenic cell death score predicts outcomes and response to transcatheter arterial chemoembolization and immunotherapy in hepatocellular carcinoma;Journal of Cancer Research and Clinical Oncology;2023-06-29

5. MARCKS is a New Prognostic Biomarker in Hepatocellular Carcinoma;International Journal of General Medicine;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3